Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Desmopressin in moderate hemophilia A patients: a treatment worth considering.

Haematologica - 1 Mar 2018

Loomans Janneke I, Kruip Marieke J H A, Carcao Manuel, Jackson Shannon, van Velzen Alice S, Peters Marjolein, Santagostino Elena, Platokouki Helen, Beckers Erik, Voorberg Jan, van der Bom Johanna G, Fijnvandraat Karin

Abstract excerpt

Desmopressin increases endogenous factor VIII levels in hemophilia A. Large inter-individual variation in the response to desmopressin is observed. Patients with a lower baseline factor VIII activity tend to show a reduced response, therefore, desmopressin is less frequently used in moderate hemophilia A patients (baseline factor VIII activity 1-5 international units/deciliter), even though factor VIII levels may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Deamino Arginine Vasopressin
Share to Factor VIII

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hemophilia A

Share to Predictive Value of Tests

Share to Prognosis

Share to Treatment Outcome

Share to von Willebrand Factor

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 29305412
DOI: 10.3324/haematol.2017.180059
PMCID: PMC5830393

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Desmopressin in moderate hemophilia A patients: a treatment worth considering.PMID 29305412Read ↗

Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.Semantic proximity Read ↗

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.Semantic proximity Read ↗

Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A.Semantic proximity Read ↗

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.Semantic proximity Read ↗

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.Semantic proximity Read ↗

Inhibitors to Factor VIII in a Family with Mild Hemophilia: Molecular Characterization and Response to Factor VIII and DesmopressinSemantic proximity Read ↗

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.Semantic proximity Read ↗

Pharmacokinetic Modelling to Predict FVIII:C Response to Desmopressin and Its Reproducibility in Nonsevere Haemophilia A Patients.Semantic proximity Read ↗

How I treat type 2 variant forms of von Willebrand disease.Semantic proximity Read ↗

Biological effect of desmopressin in eight patients with type 2N ('Normandy') von Willebrand disease. Collaborative Group.Semantic proximity Read ↗

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD.Semantic proximity Read ↗

Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.